SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Lupin reports 2.11% rise in Q4 net profit

10 May 2012 Evaluate

Lupin has reported results for fourth quarter ended March 31, 2012.

The company has posted a rise of 2.11% in its net profit at Rs 248.89 crore for the quarter ended March 31, 2012 as compared to Rs 243.75 crore for the same quarter in the previous year. Total income has increased by 19.98% at Rs 1467.74 crore for quarter under review as compared Rs 1223.33 crore for the quarter ended March 31, 2011.

On the consolidated basis, the company has posted a fall of 31.50% in its net profit at Rs 155.64 crore for the quarter ended March 31, 2012 as compared to Rs 227.20 crore for the same quarter in the previous year. However, total income has increased by 24.10% at Rs 1932.09 crore for quarter under review as compared to Rs 1556.85 crore for the quarter ended March 31, 2011.

For the full year ended March 31, 2012, the company has posted a fall of 0.69% in its net profit at Rs 804.37 crore for the year ended March 31, 2012 as compared to Rs 809.98 crore for the same period in the previous year. However, total income has increased by 19.44% at Rs 5388.32 crore for year under review as compared to Rs 4511.46 crore for the period ended March 31, 2011.

On the consolidated basis, the company has posted a rise of 0.59% in its net profit at Rs 867.65 crore for the year ended March 31, 2012 as compared to Rs 862.55 crore for the same period in the previous year.  Total income has increased by 21.50% at Rs 7097.26 crore for year under review as compared to Rs 5841.16 crore for the period ended March 31, 2011.

Lupin Share Price

2496.05 -6.85 (-0.27%)
10-Jul-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1935.25
Dr. Reddys Labs. 1245.50
Cipla 1438.75
Zydus Lifesciences 1150.50
Lupin 2496.05
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: